Ryan
Rossner, PhD.

Phase I: Personalized Assessment

Based on personal goals (longevity, cognitive performance, athletic performance), we schedule in-depth testing to establish baselines for all relevant markers.

Phase II: Intervention Architecture

We design a bespoke map of protocols based on personal testing results, trade-off tolerance, and time availability.

Phase III: Optimization Recursion

We re-assess relevant biomarkers at regular intervals, refining protocols according to individual responses as well as real-time updates in the relevant fields of research.

R&D Lead — Minicircle Inc.

Design and development of nonviral longevity and augmentation gene therapies as a safer, more affordable entry point.

Postdoc — USAF/DARPA Biostasis

Conceptual framing of drug-induced human hibernation for wounded soldiers awaiting battlefield evacuation.

PhD, Molecular Mechanisms of Aging — Kaeberlein Lab, UW

Defined the regulation and function of a xenobiotic enzyme activated by multiple major longevity interventions.

Athlete — NFL

Previous chapter of life.